Giancarlo Logroscino Selected Research

AN-1792

3/2014	Is there still any hope for amyloid-based immunotherapy for Alzheimer's disease?
2/2012	Immunotherapy for Alzheimer's disease: from anti-β-amyloid to tau-based immunization strategies.
12/2011	Anti-β-amyloid immunotherapy for Alzheimer's disease: focus on bapineuzumab.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Giancarlo Logroscino Research Topics

Disease

30	Alzheimer Disease (Alzheimer's Disease) 06/2021 - 04/2005
24	Dementia (Dementias) 02/2024 - 05/2009
23	Cognitive Dysfunction 01/2023 - 05/2009
20	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2023 - 01/2010
13	Parkinson Disease (Parkinson's Disease) 01/2023 - 09/2002
11	Stroke (Strokes) 10/2023 - 03/2009
7	Disease Progression 08/2021 - 03/2011
6	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2023 - 12/2012
6	Mental Disorders (Mental Disorder) 01/2023 - 12/2016
6	Frontotemporal Dementia (Semantic Dementia) 01/2023 - 01/2016
6	Frailty 01/2021 - 04/2012
6	Language Development Disorders (Semantic-Pragmatic Disorder) 01/2021 - 01/2014
5	Hypertension (High Blood Pressure) 10/2020 - 04/2013
4	Hearing Loss (Hearing Impairment) 11/2021 - 01/2014
3	Inflammation (Inflammations) 01/2023 - 01/2020
3	Atrophy 01/2023 - 10/2010
3	Cardiovascular Diseases (Cardiovascular Disease) 12/2017 - 02/2005
3	Muscle Spasticity (Spastic) 01/2015 - 03/2013
3	Amyloid Plaque 10/2014 - 10/2010
3	Meningoencephalitis 03/2014 - 12/2011
3	Coma (Comas) 03/2010 - 11/2005
3	Status Epilepticus (Complex Partial Status Epilepticus) 02/2010 - 11/2005
2	Insulin Resistance 01/2023 - 01/2017
2	Hallucinations (Hallucination) 01/2022 - 01/2012
2	Motor Neuron Disease (Primary Lateral Sclerosis) 07/2021 - 05/2013
2	Primary Progressive Aphasia 01/2021 - 01/2018
2	Depressive Disorder (Melancholia) 01/2021 - 01/2018
2	Bipolar Disorder (Manic Depressive Psychosis) 09/2018 - 12/2016
2	Drug-Related Side Effects and Adverse Reactions 09/2018 - 12/2016
2	Movement Disorders (Movement Disorder) 01/2018 - 03/2013
2	Malnutrition (Nutritional Deficiencies) 12/2015 - 02/2011
2	Deglutition Disorders (Dysphagia) 11/2013 - 06/2013
2	Ischemic Stroke 04/2012 - 11/2010
2	Edema (Dropsy) 02/2012 - 12/2011
2	Neoplasms (Cancer) 11/2011 - 03/2011
2	Migraine Disorders (Migraine) 08/2009 - 07/2006
1	Neurologic Manifestations (Neurological Manifestations) 11/2023
1	Cerebral Hemorrhage 10/2023

Drug/Important Bio-Agent (IBA)

20	Biomarkers (Surrogate Marker)IBA 01/2023 - 10/2011
16	Amyloid (Amyloid Fibrils)IBA 01/2023 - 10/2010
6	VaccinesIBA 11/2023 - 12/2011
6	Coffee FDA Link 01/2015 - 09/2002
5	Type A Botulinum Toxins (Botox)FDA Link 08/2015 - 03/2013
5	bapineuzumabIBA 10/2014 - 12/2011
4	Antipsychotic Agents (Antipsychotics)IBA 08/2022 - 01/2015
4	Peptides (Polypeptides)IBA 06/2019 - 10/2010
4	Proteins (Proteins, Gene)FDA Link 01/2019 - 10/2010
4	AntibodiesIBA 01/2019 - 02/2012
4	Cytochrome P-450 CYP2D6 (CYP2D6)IBA 09/2018 - 12/2016
4	HomocysteineIBA 01/2018 - 08/2004
4	solanezumabIBA 01/2018 - 03/2014
4	incobotulinumtoxinA FDA Link 08/2016 - 03/2013
4	ApolipoproteinsIBA 12/2012 - 09/2003
3	CholesterolIBA 10/2020 - 01/2017
3	tau Proteins (tau Protein)IBA 01/2019 - 02/2012
3	AntioxidantsIBA 12/2018 - 02/2011
3	Fatty Acids (Saturated Fatty Acids)IBA 12/2018 - 05/2011
3	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 12/2018 - 05/2011
3	gantenerumabIBA 01/2018 - 03/2014
3	Monoclonal AntibodiesIBA 01/2016 - 03/2014
3	AN-1792IBA 03/2014 - 12/2011
3	Apolipoproteins E (ApoE)IBA 02/2012 - 04/2005
2	Retinaldehyde (Retinal)IBA 11/2021 - 08/2015
2	Psychotropic Drugs (Psychoactive Drugs)IBA 01/2021 - 12/2017
2	HDL CholesterolIBA 10/2020 - 01/2017
2	Monounsaturated Fatty AcidsIBA 01/2017 - 05/2011
2	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 01/2017 - 05/2011
2	Riluzole FDA LinkGeneric 01/2017 - 09/2013
2	hydromethylthionineIBA 01/2016 - 01/2016
2	SmokeIBA 12/2015 - 10/2004
2	Trichloroethylene (Trichloroethene)IBA 12/2015 - 12/2008
2	Antidepressive Agents (Antidepressants)IBA 01/2015 - 10/2011
2	TeaIBA 01/2015 - 03/2009
2	Caffeine (No Doz)FDA LinkGeneric 01/2015 - 03/2009
2	Humanized Monoclonal AntibodiesIBA 10/2014 - 09/2014
2	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 03/2011 - 10/2010
2	Uric Acid (Urate)IBA 02/2011 - 10/2007
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2011 - 03/2009
2	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2011 - 04/2006
2	Anticonvulsants (Antiepileptic Drugs)IBA 02/2010 - 11/2005
2	LipidsIBA 08/2009 - 07/2006
2	IronIBA 12/2008 - 06/2006
1	Blood Glucose (Blood Sugar)IBA 02/2024
1	4- Acetamido- 4'- isothiocyanatostilbene- 2,2'- disulfonic Acid (SITS)IBA 10/2023
1	RNS60IBA 01/2023
1	Tuberculin (PPD)IBA 01/2023
1	CeramidesIBA 01/2023
1	2- carbomethoxy- 8- (3- fluoropropyl)- 3- (4- iodophenyl)tropaneIBA 08/2022

Therapy/Procedure

14	Therapeutics 03/2023 - 03/2011
8	Continuous Ambulatory Peritoneal Dialysis (CAPD) 11/2021 - 01/2014
6	Immunotherapy 01/2016 - 12/2011
5	Secondary Prevention 01/2022 - 10/2017
3	Renal Dialysis (Hemodialysis) 10/2019 - 12/2015
3	Institutionalization (Institutionalized Persons) 11/2013 - 01/2012
2	Gastrostomy 08/2021 - 06/2013
2	Noninvasive Ventilation 01/2019 - 12/2017
2	Patient Readmission 09/2018 - 12/2016
2	Tracheostomy 01/2017 - 03/2015
2	Extracorporeal Shockwave Therapy 09/2016 - 01/2014
2	Injections 12/2014 - 03/2013